Klin Onkol 2021; 34(3): 180-184.
DOI: 10.48095/ccko2021180.
Keywords: oncologic disease – malignant disease – social phactors – psyche –stress
Authors: Adam Zdeněk, Adamová Zuzana, Klimeš Jeroným, Boleloucký Zdeněk2021-06-15:Social factors influence the course and prognosis of malignat diseases
Keywords: oncologic disease – malignant disease – social phactors – psyche –stress
Authors: Adam Zdeněk, Adamová Zuzana, Klimeš Jeroným, Boleloucký Zdeněk2021-06-15:Social factors influence the course and prognosis of malignat diseases
Klin Onkol 2021; 34(3): 185-191.
DOI: 10.48095/ccko2021185.
Keywords: castration-refractory prostate cancer – androgen antagonists – antineoplastic agents – drug toxicity – survival
Authors: Büchler Tomáš2021-06-15:Current treatment of non-metastatic castration-refractory prostate cancer
Keywords: castration-refractory prostate cancer – androgen antagonists – antineoplastic agents – drug toxicity – survival
Authors: Büchler Tomáš2021-06-15:Current treatment of non-metastatic castration-refractory prostate cancer
Klin Onkol 2021; 34(3): 192-201.
DOI: 10.48095/ccko2021192.
Keywords: venous access – anticancer treatment – PICC – port – extravasation
Authors: Maňásek Viktor, Charvát Jiří, Chovanec Vendelín, Sirotek Lukáš, Linke Zdeněk, Tuček Štěpán, Šenkyřík Michal, Michálek Pavel, Polák Martin, Fricová Jitka, Daniš Lukáš, Šeflová Lenka, Lisová Kateřina, Douglas Martina2021-06-15:Indications for venous access in oncology – recommendations of national professional societies and current state in the Czech Republic
Keywords: venous access – anticancer treatment – PICC – port – extravasation
Authors: Maňásek Viktor, Charvát Jiří, Chovanec Vendelín, Sirotek Lukáš, Linke Zdeněk, Tuček Štěpán, Šenkyřík Michal, Michálek Pavel, Polák Martin, Fricová Jitka, Daniš Lukáš, Šeflová Lenka, Lisová Kateřina, Douglas Martina2021-06-15:Indications for venous access in oncology – recommendations of national professional societies and current state in the Czech Republic
Klin Onkol 2021; 34(3): 202-210.
DOI: 10.48095/ccko2021202.
Keywords: mechanobiology – cancer – extracellular matrix – mechanotransduction – shear stress – therapy resistence
Authors: Raudenská Martina, Navrátil Jiří, Gumulec Jaromír, Masařík Michal2021-06-15:Mechanobiology of cancerogenesis
Keywords: mechanobiology – cancer – extracellular matrix – mechanotransduction – shear stress – therapy resistence
Authors: Raudenská Martina, Navrátil Jiří, Gumulec Jaromír, Masařík Michal2021-06-15:Mechanobiology of cancerogenesis
Klin Onkol 2021; 34(3): 211-219.
DOI: 10.48095/ccko2021211.
Keywords: COVID-19 – cancer – CRP – white blood cells – coagulation – fever – recommendation
Authors: Šálek Tomáš, Slopovský Ján, Pörsök Štefan, Pazderová Natália, Mináriková Zuzana, Zomborská Eva, Špánik Benjamin2021-06-15:COVID-19 and oncological disease
Keywords: COVID-19 – cancer – CRP – white blood cells – coagulation – fever – recommendation
Authors: Šálek Tomáš, Slopovský Ján, Pörsök Štefan, Pazderová Natália, Mináriková Zuzana, Zomborská Eva, Špánik Benjamin2021-06-15:COVID-19 and oncological disease
Klin Onkol 2021; 34(3): 220-234.
DOI: 10.48095/ccko2021220.
Keywords: radiation therapy – prostate cancer – cell culture – copy number variation of genes – transcriptional activity of genes – micro-RNA – apoptosis – DNA repair
Authors: Kutilin Denis2021-06-15:Genetic and epigenetic bases of prostate tumor cell radioresistance
Keywords: radiation therapy – prostate cancer – cell culture – copy number variation of genes – transcriptional activity of genes – micro-RNA – apoptosis – DNA repair
Authors: Kutilin Denis2021-06-15:Genetic and epigenetic bases of prostate tumor cell radioresistance
Klin Onkol 2021; 34(3): 235-240.
DOI: 10.48095/ccko2021235.
Keywords: epithelioid hemangioendothelioma – PET/ CT– treatment
Authors: Koukalová Renata, Šedo Jiří, Adámková Krákorová Dagmar, Šimková Zuzana, Fabián Pavel, Szturz Petr2021-06-15:Epithelioid hemangioendothelioma on PET/CT scan
Keywords: epithelioid hemangioendothelioma – PET/ CT– treatment
Authors: Koukalová Renata, Šedo Jiří, Adámková Krákorová Dagmar, Šimková Zuzana, Fabián Pavel, Szturz Petr2021-06-15:Epithelioid hemangioendothelioma on PET/CT scan
Klin Onkol 2021; 34(3): 241-243.
DOI: 10.48095/ccko2021241.
Authors: Novotný Tomáš, Řehák Zdeněk, Budinský Michal, Dvořáček Petr, Vašina Jiří, Šlampa Pavel, Slávik Marek2021-06-15:The use of PET/ CT with a hypoxia marker (18F-MISO) in radiotherapy treatment planning
Authors: Novotný Tomáš, Řehák Zdeněk, Budinský Michal, Dvořáček Petr, Vašina Jiří, Šlampa Pavel, Slávik Marek2021-06-15:The use of PET/ CT with a hypoxia marker (18F-MISO) in radiotherapy treatment planning
Klin Onkol 2021; 34(Suppl 1): 6-19.
DOI: 10.48095/ccko20216.
Keywords: karcinom plic – diagnostika karcinomu plic – screening karcinomu plic
Authors: Skřičková Jana, Nebeský Tomáš, Kadlec Bohdan, Hejduk Karel, Májek Ondřej, Vašáková Martina, Peterová-Čierná Ivana2021-06-01:Lung cancer – diagnosis and early detection
Keywords: karcinom plic – diagnostika karcinomu plic – screening karcinomu plic
Authors: Skřičková Jana, Nebeský Tomáš, Kadlec Bohdan, Hejduk Karel, Májek Ondřej, Vašáková Martina, Peterová-Čierná Ivana2021-06-01:Lung cancer – diagnosis and early detection
Klin Onkol 2021; 34(Suppl 1): 20-28.
DOI: 10.48095/ccko202120.
Keywords: lung cancer – comprehensive molecular profiling – molecular tumor board – precision oncology – targeted therapy
Authors: Bílek Ondřej, Bořilová Simona, Grell Peter, Kiss Igor2021-06-01:The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer
Keywords: lung cancer – comprehensive molecular profiling – molecular tumor board – precision oncology – targeted therapy
Authors: Bílek Ondřej, Bořilová Simona, Grell Peter, Kiss Igor2021-06-01:The role of multidisciplinary team and molecular tumor board in the treatment of a patient with lung cancer
Klin Onkol 2021; 34(Suppl 1): 29-34.
DOI: 10.48095/ccko202129.
Keywords: predictive testing – non-small cell lung carcinoma – driver mutations – PD-L1
Authors: Dundr Pavel, Matěj Radoslav, Němejcová Kristýna, Bártů Michaela, Stružinská Ivana 2021-06-01:Predictive testing in non-small cell lung carcinoma
Keywords: predictive testing – non-small cell lung carcinoma – driver mutations – PD-L1
Authors: Dundr Pavel, Matěj Radoslav, Němejcová Kristýna, Bártů Michaela, Stružinská Ivana 2021-06-01:Predictive testing in non-small cell lung carcinoma
Klin Onkol 2021; 34(Suppl 1): 35-42.
DOI: 10.48095/ccko202135.
Keywords: karcinom plic – VATS – imunoterapie – stadia NSCLC
Authors: Jedlička Václav2021-06-01:Surgical treatment of lung cancer
Keywords: karcinom plic – VATS – imunoterapie – stadia NSCLC
Authors: Jedlička Václav2021-06-01:Surgical treatment of lung cancer
Klin Onkol 2021; 34(Suppl 1): 43-47.
DOI: 10.48095/ccko202143.
Keywords: lung cancer – early stage – treatment
Authors: Krejčí Daniel, Třebický Ferdinand, Fanta Jan, Opálka Petr, Pauk Norbert.2021-06-01:New treatment modalities in the early stage and locally advanced non-small cell lung cancer
Keywords: lung cancer – early stage – treatment
Authors: Krejčí Daniel, Třebický Ferdinand, Fanta Jan, Opálka Petr, Pauk Norbert.2021-06-01:New treatment modalities in the early stage and locally advanced non-small cell lung cancer
Klin Onkol 2021; 34(Suppl 1): 48-52.
DOI: 10.48095/ccko202148.
Keywords: non-small cell lung cancer – targeted therapy – tyrosine kinase inhibitors
Authors: Svatoň Martin2021-06-01:Targeted therapy of non-small cell lung cancer
Keywords: non-small cell lung cancer – targeted therapy – tyrosine kinase inhibitors
Authors: Svatoň Martin2021-06-01:Targeted therapy of non-small cell lung cancer
Klin Onkol 2021; 34(Suppl 1): 54-64.
DOI: 10.48095/ccko202154.
Keywords: non-small cell lung cancer – immunotherapy – programmed cell death protein 1
Authors: Bílek Ondřej, Bořilová Simona, Grell Peter, Kiss Igor2021-06-01:Immunotherapy in the treatment of non-small cell lung cancer
Keywords: non-small cell lung cancer – immunotherapy – programmed cell death protein 1
Authors: Bílek Ondřej, Bořilová Simona, Grell Peter, Kiss Igor2021-06-01:Immunotherapy in the treatment of non-small cell lung cancer
